Amarin’s AMR101 for Huntington’s disease Marketing Authorization Application accepted for review by EMEA
April 8, 2009
Read more ยป
Home
ProSeed Capital
About
Investor Extranet
News Releases
Team
Advisory Services
Search:
Your Privacy
|
Legal Notes
| info@proseedcapital.com